poisar

Stocks · News reference

Analysts Adjust Price Targets for ICON Public Limited Company Following Q3 Earnings

Fiscal.ai

Following the company's Q3 2026 earnings call, multiple financial institutions including Deutsche Bank, RBC, and Truist Securities have updated their price targets for ICON.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. BenzingaBenzinga Insights

    Icon Q3 2026 Earnings Call Transcript

    Icon (NASDAQ:ICLR) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For

  2. Globenewswire IncResearchandmarkets.Com

    Rare Disease Contract Research Organization (CRO) Market Outlook 2026-2030: Investment Trends, Strategic Profiles and Revenue Share Outlook

    The global rare disease CRO market is projected to grow from $2.07 billion in 2025 to $3.16 billion by 2030, with an 8.9% CAGR. Growth is driven by expanding gene and cell therapy pipelines, increasing orphan drug approvals, precision medicine adoption, and decentralized clinical trials. Key trends include AI integration, patient registries, and real-world evidence utilization.